Search
Orchestra Biomed Holdings Inc
OBIOAdd to Watchlist
5.750USD
+0.050+0.88%
Market hours 11/10, 15:12（ET）
345.63MMarket Cap
LossP/E TTM
Orchestra Biomed Holdings Inc (OBIO) Stock Price Target & Forecast
Analyst Rating
Based on 7 analysts giving stock ratings to Orchestra Biomed Holdings Inc in the past month.
Buy
2 Strong Buy
5 Buy
0 Hold
0 Sell
0 Strong Sell
Target Price
12.429USD+110.30%
OBIO Analyst Recommendation Trends
In the current month, OBIO has received 5 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. OBIO average Analyst price target in the last month is 12.429.
2026-11
2026-10
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
2
2
1
1
1
1
1
1
5
5
5
5
5
6
6
6
0
0
1
1
1
1
1
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
7
7
7
7
7
8
8
8
OBIO Analyst Rating for Peer Comparison
Updated: Nov 5, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
Intuitive Surgical Inc
ISRG
11
13
9
1
0
34
Boston Scientific Corp
BSX
7
15
11
0
0
33
Thermo Fisher Scientific Inc
TMO
10
17
3
0
0
30
Edwards Lifesciences Corp
EW
10
14
6
0
0
30
Veeva Systems Inc
VEEV
8
13
7
1
0
29
Danaher Corp
DHR
11
13
3
0
0
27
Waters Corp
WAT
8
10
8
0
0
26
Agilent Technologies Inc
A
6
11
7
0
0
24
Resmed Inc
RMD
3
8
10
1
1
23
GE Healthcare Technologies Inc
GEHC
6
10
7
0
0
23
Financial Forecasting
Based on analysts' estimates, OBIO EPS is projected to reach -0.401 in FY2026Q3, following reported EPS of -0.377 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2025Q4
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
Forecast
-0.38
-0.43
-0.39
-0.40
-0.41
Actual
0.10
-0.33
-0.38
--
--
Surprise
+125.54%
+23.59%
+3.74%
--
--
FAQs
What is Orchestra Biomed Holdings Inc's expected revenue for the next quarter?
Orchestra Biomed Holdings Inc's expected revenue is 106.00K.
What is Orchestra Biomed Holdings Inc's price target?
Analysts forecast that Orchestra Biomed Holdings Inc's price target is USD 12.43, with the highest forecast at USD 20.00 and the lowest forecast at USD 9.00.
How have Orchestra Biomed Holdings IncOBIO's recent earnings per share performed?
The market expectation was USD -0.38, while Orchestra Biomed Holdings IncOBIO's earnings per share (EPS) for the previous quarter was USD -0.33. EPS for the next quarter is expected at USD -0.40.
What is the analyst rating for Orchestra Biomed Holdings Inc?
Based on the ratings of Orchestra Biomed Holdings Inc's stock from 7 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.